Walgreens Boots Alliance Q4 Earnings Beat Estimates

Loading...
Loading...
  • Retail pharmacy chain Walgreens Boots Alliance Inc WBA reported fourth-quarter FY21 sales growth of 12.8% year-over-year to $34.26 billion, and an 11.8% increase on a constant currency basis, beating the consensus of $33.3 billion.
  • Adjusted EPS improved by 29.5% Y/Y to $1.17, beating the consensus of $1.02.
  • The gross margin expanded by 108 bps to 21.9%, and the adjusted gross margin was 21.7%. The operating income increased by 49.7% Y/Y to $910 million.
  • U.S. segment: Sales were $28.8 billion (+6.6% Y/Y) with a comparable sales increase of 8.1%. Pharmacy sales increased 6.7% Y/Y, and comparable pharmacy sales increased 8.9%. Retail sales increased 6.5% Y/Y, and comparable retail sales increased 6.2%.
  • International segment: Sales totaled $5.5 billion (+61.8% Y/Y), including a favorable currency impact of 9.2%. Boots UK comparable pharmacy sales increased 11.4%.
  • Walgreens generated cash from operating activities for the fiscal year totaled $5.56 billion, and Free cash flow was $4.2 billion.
  • Walgreens held cash and equivalents of $1.27 billion as of August 31, 2021.
  • Walgreens surpassed the COVID-19 vaccination goal by providing 13.5 million vaccinations in the quarter and 34.6 million in FY21.
  • Price Action: WBA shares are trading higher by 1.04% at $47.74 during the premarket session on Thursday.
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsMoversTrading IdeasBriefs
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...